Reliability of Magnetic Resonance Spectroscopy and Positron Emission Tomography Computed Tomography in Differentiating Metastatic Brain Tumor Recurrence from Radiation Necrosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reliability of Magnetic Resonance Spectroscopy and Positron Emission Tomography Computed Tomography in Differentiating Metastatic Brain Tumor Recurrence from Radiation Necrosis
Authors
Keywords
-
Journal
World Neurosurgery
Volume 151, Issue -, Pages e1059-e1068
Publisher
Elsevier BV
Online
2021-05-28
DOI
10.1016/j.wneu.2021.05.064
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnostic Accuracy and Confidence of [18F] FDG PET/MRI in comparison with PET or MRI alone in Head and Neck Cancer
- (2020) Jisang Park et al. Scientific Reports
- Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2
- (2018) Mario Muto et al. Radiologia Medica
- Diagnosis and Management of Radiation Necrosis in Patients With Brain Metastases
- (2018) Balamurugan Vellayappan et al. Frontiers in Oncology
- Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology
- (2017) Jay S. Detsky et al. JOURNAL OF NEURO-ONCOLOGY
- Diagnostic Accuracy of PET, SPECT, and Arterial Spin-Labeling in Differentiating Tumor Recurrence from Necrosis in Cerebral Metastasis after Stereotactic Radiosurgery
- (2015) G. Lai et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases
- (2015) Zachary A. Kohutek et al. JOURNAL OF NEURO-ONCOLOGY
- Role of magnetic resonance spectroscopy for the differentiation of recurrent glioma from radiation necrosis: A systematic review and meta-analysis
- (2014) Hui Zhang et al. EUROPEAN JOURNAL OF RADIOLOGY
- Recurrent glioblastoma multiforme versus radiation injury: a multiparametric 3-T MR approach
- (2014) Alfonso Di Costanzo et al. Radiologia Medica
- Analysis of the layering pattern of the apparent diffusion coefficient (ADC) for differentiation of radiation necrosis from tumour progression
- (2012) Jihoon Cha et al. EUROPEAN RADIOLOGY
- MR Spectroscopy Using Normalized and Non-normalized Metabolite Ratios for Differentiating Recurrent Brain Tumor from Radiation Injury
- (2011) Augusto E. Elias et al. ACADEMIC RADIOLOGY
- Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis
- (2011) Giuseppe Minniti et al. Radiation Oncology
- Dual phase FDG-PET imaging of brain metastases provides superior assessment of recurrence versus post-treatment necrosis
- (2010) Laura L. Horky et al. JOURNAL OF NEURO-ONCOLOGY
- Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery
- (2010) Koichi Mitsuya et al. JOURNAL OF NEURO-ONCOLOGY
- Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas
- (2010) Frederic G Dhermain et al. LANCET NEUROLOGY
- Irradiated Volume as a Predictor of Brain Radionecrosis After Linear Accelerator Stereotactic Radiosurgery
- (2009) Brian J. Blonigen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Distinction between glioma progression and post-radiation change by combined physiologic MR imaging
- (2009) Eiji Matsusue et al. NEURORADIOLOGY
- CAN STANDARD MAGNETIC RESONANCE IMAGING RELIABLY DISTINGUISH RECURRENT TUMOR FROM RADIATION NECROSIS AFTER RADIOSURGERY FOR BRAIN METASTASES? A RADIOGRAPHIC-PATHOLOGICAL STUDY
- (2008) Ivan M. Dequesada et al. NEUROSURGERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started